Exact Mass: 313.0997

Exact Mass Matches: 313.0997

Found 99 metabolites which its exact mass value is equals to given mass value 313.0997, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Melicopine

1,3-Dioxolo[4,5-c]acridin-6(11H)-one,4,5-dimethoxy-11-methyl-

C17H15NO5 (313.095)


   

Amoxapine

13-chloro-10-(piperazin-1-yl)-2-oxa-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,9,12,14-heptaene

C17H16ClN3O (313.0982)


Amoxapine, the N-demethylated derivative of the antipsychotic agent loxapine, is a dibenzoxazepine-derivative tricyclic antidepressant (TCA). TCAs are structurally similar to phenothiazines. They contain a tricyclic ring system with an alkyl amine substituent on the central ring. In non-depressed individuals, amoxapine does not affect mood or arousal, but may cause sedation. In depressed individuals, amoxapine exerts a positive effect on mood. TCAs are potent inhibitors of serotonin and norepinephrine reuptake. In addition, TCAs down-regulate cerebral cortical β-adrenergic receptors and sensitize post-synaptic serotonergic receptors with chronic use. The antidepressant effects of TCAs are thought to be due to an overall increase in serotonergic neurotransmission. TCAs also block histamine H1 receptors, α1-adrenergic receptors and muscarinic receptors, which accounts for their sedative, hypotensive and anticholinergic effects (e.g. blurred vision, dry mouth, constipation, urinary retention), respectively. See toxicity section below for a complete listing of side effects. Amoxapine may be used to treat neurotic and reactive depressive disorders, endogenous and psychotic depression, and mixed symptoms of depression and anxiety or agitation. N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators

   

Avenanthramide 1f

2-{[(2E)-1-hydroxy-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-ylidene]amino}benzoate

C17H15NO5 (313.095)


Avenanthramide 1f is a polyphenol compound found in foods of plant origin (PMID: 20428313)

   

Avenanthramide E

2-{[(2Z)-1-hydroxy-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-ylidene]amino}benzoate

C17H15NO5 (313.095)


(Z)-Avenanthramide E is found in cereals and cereal products. (Z)-Avenanthramide E is isolated from oat. Isolated from the oat Avena sativa. Avenanthramide E is found in oat and cereals and cereal products.

   

4-(4-Guanidinobenzoyloxy)phenylacetate

2-(4-{4-[(diaminomethylidene)amino]benzoyloxy}phenyl)acetic acid

C16H15N3O4 (313.1063)


   

Benorilate

N-{4-[2-(acetyloxy)benzoyloxy]phenyl}ethanimidate

C17H15NO5 (313.095)


N - Nervous system > N02 - Analgesics > N02B - Other analgesics and antipyretics > N02BA - Salicylic acid and derivatives D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D018501 - Antirheumatic Agents

   

Mitonafide

3-[2-(dimethylamino)ethyl]-11-nitro-3-azatricyclo[7.3.1.0^{5,13}]trideca-1(13),5,7,9,11-pentaene-2,4-dione

C16H15N3O4 (313.1063)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007364 - Intercalating Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D000970 - Antineoplastic Agents

   

Pipethiadene

4-{6,8-dithiatricyclo[8.4.0.0^{3,7}]tetradeca-1(14),3(7),4,10,12-pentaen-2-ylidene}-1-methylpiperidine

C18H19NS2 (313.0959)


   

N-(5-Chlorosalicyloyl)-8-aminocaprylic acid

8-{[(5-chloro-2-hydroxyphenyl)(hydroxy)methylidene]amino}octanoate

C15H20ClNO4 (313.1081)


   
   

Penicidone B

Penicidone B

C17H15NO5 (313.095)


   

Melicopidine

Melicopidine

C17H15NO5 (313.095)


   
   

Maybridge3_000801

Maybridge3_000801

C12H19N5OS2 (313.1031)


   
   

S-sinapyl-L-cysteine

S-sinapyl-L-cysteine

C14H19NO5S (313.0984)


   

N-methylanhydroschumannificine

N-methylanhydroschumannificine

C17H15NO5 (313.095)


   

Tecleanthin

Tecleanthin

C17H15NO5 (313.095)


   

desulfobenzyl GL|desulfoglucotropaeolin|DS-GTL

desulfobenzyl GL|desulfoglucotropaeolin|DS-GTL

C14H19NO5S (313.0984)


   

(E)-3-(3,4-dihydroxyphenyl)-N-[2-(4-hydroxyphenyl)-2-oxoethyl]prop-2-enamide|tribulusamide D

(E)-3-(3,4-dihydroxyphenyl)-N-[2-(4-hydroxyphenyl)-2-oxoethyl]prop-2-enamide|tribulusamide D

C17H15NO5 (313.095)


   
   
   

amoxapine

amoxapine

C17H16ClN3O (313.0982)


N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators CONFIDENCE standard compound; INTERNAL_ID 902; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7940; ORIGINAL_PRECURSOR_SCAN_NO 7938 CONFIDENCE standard compound; INTERNAL_ID 902; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7961; ORIGINAL_PRECURSOR_SCAN_NO 7960 CONFIDENCE standard compound; INTERNAL_ID 902; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7991; ORIGINAL_PRECURSOR_SCAN_NO 7989 CONFIDENCE standard compound; INTERNAL_ID 902; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7990; ORIGINAL_PRECURSOR_SCAN_NO 7988 CONFIDENCE standard compound; INTERNAL_ID 902; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7970; ORIGINAL_PRECURSOR_SCAN_NO 7967 CONFIDENCE standard compound; INTERNAL_ID 902; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7997; ORIGINAL_PRECURSOR_SCAN_NO 7994

   

Salinosporamide A

Salinosporamide A

C15H20ClNO4 (313.1081)


A salinosporamide in which the core (1R)-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione skeleton is substituted at positions 1, 4, and 5 by (1S)-cyclohex-2-en-1-yl(hydroxy)methyl, 2-chloroethyl, and methyl groups, respectively (the 1R,4R,5S diastereoisomer). A potent proteasome inhibitor, it has attracted interest for potential use in the treatment of various cancers.

   

Benorilate

Benorilate

C17H15NO5 (313.095)


N - Nervous system > N02 - Analgesics > N02B - Other analgesics and antipyretics > N02BA - Salicylic acid and derivatives D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D018501 - Antirheumatic Agents

   

Avenanthramide 1f

2-[(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamido]benzoic acid

C17H15NO5 (313.095)


   

Avenanthramide E

2-[(2Z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamido]benzoic acid

C17H15NO5 (313.095)


   

(1R,2S)-Methyl 1-amino-2-vinylcyclopropanecarboxylate 4-methylbenzenesulfonate

(1R,2S)-Methyl 1-amino-2-vinylcyclopropanecarboxylate 4-methylbenzenesulfonate

C14H19NO5S (313.0984)


   

tert-Butyl 7,8-dihydro-2-(methylsulfonyl)pyrido[4,3-d]pyrimidine-6(5H)-carboxylate

tert-Butyl 7,8-dihydro-2-(methylsulfonyl)pyrido[4,3-d]pyrimidine-6(5H)-carboxylate

C13H19N3O4S (313.1096)


   
   

2-(1-Oxy-pyridin-2-yl)-1,1,3,3-tetramethylisothiouronium tetrafluoroborate

2-(1-Oxy-pyridin-2-yl)-1,1,3,3-tetramethylisothiouronium tetrafluoroborate

C10H16BF4N3OS (313.1043)


   

1,4-Dihydro-1-(6-methoxy-1H-benzimidazol-2-yl)-3,5-dimethyl-4-oxo-2-pyridinecarboxylic acid

1,4-Dihydro-1-(6-methoxy-1H-benzimidazol-2-yl)-3,5-dimethyl-4-oxo-2-pyridinecarboxylic acid

C16H15N3O4 (313.1063)


   

Boc-D-N-Me-Phe-OH

Boc-D-N-Me-Phe-OH

C15H20ClNO4 (313.1081)


   

9,10-Anthracenedione,1-amino-4-hydroxy-2-(2-methoxyethoxy)-

9,10-Anthracenedione,1-amino-4-hydroxy-2-(2-methoxyethoxy)-

C17H15NO5 (313.095)


   

Boc-(R)-3-AMino-4-(3-chloro-phenyl)-butyric acid

Boc-(R)-3-AMino-4-(3-chloro-phenyl)-butyric acid

C15H20ClNO4 (313.1081)


   

Fmoc-aoac-oh

Fmoc-aoac-oh

C17H15NO5 (313.095)


   

BenzeneMethanol, α-(aminomethyl)-α-(4-chlorophenyl)-4-(1H-pyrazol-4-yl)-

BenzeneMethanol, α-(aminomethyl)-α-(4-chlorophenyl)-4-(1H-pyrazol-4-yl)-

C17H16ClN3O (313.0982)


   

(2S, 3S)-3-(Boc-amino)-2-Methyl-3-(4-chlorophenyl)propionic acid

(2S, 3S)-3-(Boc-amino)-2-Methyl-3-(4-chlorophenyl)propionic acid

C15H20ClNO4 (313.1081)


   

YM 976

4-(3-Chlorophenyl)-1,7-diethylpyrido[2,3-d]pyrimidin-2(1H)-one

C17H16ClN3O (313.0982)


   

3-(2,6-Dimethylmorpholin-4-yl)-4-methylsulfonylbenzoicacid

3-(2,6-Dimethylmorpholin-4-yl)-4-methylsulfonylbenzoicacid

C14H19NO5S (313.0984)


   

Boc-(R)-3-amino-4-(4-chlorophenyl)-butyric acid

Boc-(R)-3-amino-4-(4-chlorophenyl)-butyric acid

C15H20ClNO4 (313.1081)


   

Ethyl 4-(methylsulfonyl)-2-(4-morpholinyl)benzoate

Ethyl 4-(methylsulfonyl)-2-(4-morpholinyl)benzoate

C14H19NO5S (313.0984)


   

Boc-(S)-3-amino-4-(2-chlorophenyl)-butyric acid

Boc-(S)-3-amino-4-(2-chlorophenyl)-butyric acid

C15H20ClNO4 (313.1081)


   

Boc-(S)-3-Amino-4-(3-chloro-phenyl)-butyric acid

Boc-(S)-3-Amino-4-(3-chloro-phenyl)-butyric acid

C15H20ClNO4 (313.1081)


   

Boc-(S)-3-Amino-4-(4-chloro-phenyl)-butyric acid

Boc-(S)-3-Amino-4-(4-chloro-phenyl)-butyric acid

C15H20ClNO4 (313.1081)


   

2-N-BOC-2-AMINOMETHYL-3-(3-CHLORO-PHENYL)-PROPIONIC ACID

2-N-BOC-2-AMINOMETHYL-3-(3-CHLORO-PHENYL)-PROPIONIC ACID

C15H20ClNO4 (313.1081)


   

2-N-BOC-2-AMINOMETHYL-3-(4-CHLORO-PHENYL)-PROPIONIC ACID

2-N-BOC-2-AMINOMETHYL-3-(4-CHLORO-PHENYL)-PROPIONIC ACID

C15H20ClNO4 (313.1081)


   

benzyl 4-(methanesulfonyloxy)piperidine-1-carboxylate

benzyl 4-(methanesulfonyloxy)piperidine-1-carboxylate

C14H19NO5S (313.0984)


   

N-Hexylpyridinium Trifluoromethanesulfonate

N-Hexylpyridinium Trifluoromethanesulfonate

C12H18F3NO3S (313.0959)


   

3-[1-[(3,5-difluorophenyl)methyl]indol-3-yl]prop-2-enoic acid

3-[1-[(3,5-difluorophenyl)methyl]indol-3-yl]prop-2-enoic acid

C18H13F2NO2 (313.0914)


   

3-(4-fluorophenyl)-5-p-tolyl-4,5-dihydro-1h-pyrazole-1-carbothioamide

3-(4-fluorophenyl)-5-p-tolyl-4,5-dihydro-1h-pyrazole-1-carbothioamide

C17H16FN3S (313.1049)


   

Boc-(R)-3-amino-4-(2-chlorophenyl)-butyric acid

Boc-(R)-3-amino-4-(2-chlorophenyl)-butyric acid

C15H20ClNO4 (313.1081)


   

2-chloro-N-(2-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide

2-chloro-N-(2-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide

C14H18BClFNO3 (313.1052)


   

2,4-dimethoxy-4-nitrochalcone

2,4-dimethoxy-4-nitrochalcone

C17H15NO5 (313.095)


   

2,4-dimethoxy-2-nitrochalcone

2,4-dimethoxy-2-nitrochalcone

C17H15NO5 (313.095)


   

6-Fluoro-3-indolyl-b-D-galactopyranoside

6-Fluoro-3-indolyl-b-D-galactopyranoside

C14H16FNO6 (313.0962)


   

5-(4-Chlorophenyl)-3-p-tolyl-4,5-dihydro-1H-pyrazole-1-carboxamide

5-(4-Chlorophenyl)-3-p-tolyl-4,5-dihydro-1H-pyrazole-1-carboxamide

C17H16ClN3O (313.0982)


   

8-Azabicyclo(3.2.1]octane, 3-(3,4-dichlorophenyl)-2-(methoxymethyl)-8-methyl-, (1R,2R,3S,5S)-

8-Azabicyclo(3.2.1]octane, 3-(3,4-dichlorophenyl)-2-(methoxymethyl)-8-methyl-, (1R,2R,3S,5S)-

C16H21Cl2NO (313.1)


   
   

N-(5-Chlorosalicyloyl)-8-aminocaprylic acid

N-(5-Chlorosalicyloyl)-8-aminocaprylic acid

C15H20ClNO4 (313.1081)


   

4-[2-(4-Methoxycarbonylphenyl)iminohydrazinyl]benzoic acid methyl ester

4-[2-(4-Methoxycarbonylphenyl)iminohydrazinyl]benzoic acid methyl ester

C16H15N3O4 (313.1063)


   

N-(2,3-dimethylphenyl)-5-(2-fluorophenyl)-6H-1,3,4-thiadiazin-2-amine

N-(2,3-dimethylphenyl)-5-(2-fluorophenyl)-6H-1,3,4-thiadiazin-2-amine

C17H16FN3S (313.1049)


   

4-Chloro-2-[[(1-methyl-5-phenyl-2-imidazolyl)amino]methyl]phenol

4-Chloro-2-[[(1-methyl-5-phenyl-2-imidazolyl)amino]methyl]phenol

C17H16ClN3O (313.0982)


   

N,N,1-triethyl-2-sulfanyl-1H-1,3-benzodiazole-5-sulfonamide

N,N,1-triethyl-2-sulfanyl-1H-1,3-benzodiazole-5-sulfonamide

C13H19N3O2S2 (313.0919)


   

2-[Bis(5-methylfuran-2-yl)methyl]-6-nitrophenol

2-[Bis(5-methylfuran-2-yl)methyl]-6-nitrophenol

C17H15NO5 (313.095)


   

3-(4-chlorophenyl)-2-methyl-5,6,7,8-tetrahydropyrazolo[5,1-b]quinazolin-9(4H)-one

3-(4-chlorophenyl)-2-methyl-5,6,7,8-tetrahydropyrazolo[5,1-b]quinazolin-9(4H)-one

C17H16ClN3O (313.0982)


   

Marizomib

Marizomib

C15H20ClNO4 (313.1081)


C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2160 - Proteasome Inhibitor C471 - Enzyme Inhibitor

   

4-[4-(4-Methyl-2-methylamino-thiazol-5-YL)-pyrimidin-2-ylamino]-phenol

4-[4-(4-Methyl-2-methylamino-thiazol-5-YL)-pyrimidin-2-ylamino]-phenol

C15H15N5OS (313.0997)


   

(2s,3s)-3-Formyl-2-({[(4-methylphenyl)sulfonyl]amino}methyl)pentanoic acid

(2s,3s)-3-Formyl-2-({[(4-methylphenyl)sulfonyl]amino}methyl)pentanoic acid

C14H19NO5S (313.0984)


   
   

Avenanthramide 1f

2-{[(2E)-1-hydroxy-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-ylidene]amino}benzoate

C17H15NO5 (313.095)


Avenanthramide 1f is a polyphenol compound found in foods of plant origin (PMID: 20428313)

   

7,8-Dihydropteroate

7,8-Dihydropteroate

C14H13N6O3- (313.1049)


A pteroate that is the conjugate base of 7,8-dihydropteroic acid, arising from deprotonation of the carboxy group.

   

Dihydroisopteroate

Dihydroisopteroate

C14H13N6O3- (313.1049)


   

Ethyl 6-(4-methoxyphenoxy)imidazo[1,2-b]pyridazine-2-carboxylate

Ethyl 6-(4-methoxyphenoxy)imidazo[1,2-b]pyridazine-2-carboxylate

C16H15N3O4 (313.1063)


   

2-[[2,3-Dihydro-1,4-benzodioxin-6-yl(oxo)methyl]amino]benzoic acid methyl ester

2-[[2,3-Dihydro-1,4-benzodioxin-6-yl(oxo)methyl]amino]benzoic acid methyl ester

C17H15NO5 (313.095)


   

2-Nitrobenzoic acid [1-(4-methylphenyl)-1-oxopropan-2-yl] ester

2-Nitrobenzoic acid [1-(4-methylphenyl)-1-oxopropan-2-yl] ester

C17H15NO5 (313.095)


   

N-(2,3-dihydro-1H-inden-5-yl)-2-[(2-nitro-3-pyridinyl)oxy]acetamide

N-(2,3-dihydro-1H-inden-5-yl)-2-[(2-nitro-3-pyridinyl)oxy]acetamide

C16H15N3O4 (313.1063)


   

N-(2,6-Dimethyl-phenyl)-2-(9H-purin-6-ylsulfanyl)-acetamide

N-(2,6-Dimethyl-phenyl)-2-(9H-purin-6-ylsulfanyl)-acetamide

C15H15N5OS (313.0997)


   

N-[3-carbamoyl-5-[diethylamino(oxo)methyl]-4-methyl-2-thiophenyl]carbamic acid methyl ester

N-[3-carbamoyl-5-[diethylamino(oxo)methyl]-4-methyl-2-thiophenyl]carbamic acid methyl ester

C13H19N3O4S (313.1096)


   

Lnape 2:0/N-3:0

Lnape 2:0/N-3:0

C10H20NO8P (313.0926)


   

Lnape 3:0/N-2:0

Lnape 3:0/N-2:0

C10H20NO8P (313.0926)


   

[1-Acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] propanoate

[1-Acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] propanoate

C10H20NO8P (313.0926)


   
   

AT13148

AT13148

C17H16ClN3O (313.0982)


AT13148 is an orally active and ATP-competitive, multi-AGC kinase inhibitor with IC50s of 38 nM/402 nM/50 nM, 8 nM, 3 nM, and 6 nM/4 nM for Akt1/2/3, p70S6K, PKA, and ROCKI/II, respectively.

   

(2e)-3-[(7s)-8,11-dihydroxy-12-methyl-2-oxo-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),4,8,10,12-pentaen-5-yl]prop-2-enimidic acid

(2e)-3-[(7s)-8,11-dihydroxy-12-methyl-2-oxo-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),4,8,10,12-pentaen-5-yl]prop-2-enimidic acid

C16H15N3O4 (313.1063)


   

2-amino-3-{[3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-en-1-yl]sulfanyl}propanoic acid

2-amino-3-{[3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-en-1-yl]sulfanyl}propanoic acid

C14H19NO5S (313.0984)


   

(1r,4r,5s)-4-(2-chloroethyl)-1-[(s)-(1s)-cyclohex-2-en-1-yl(hydroxy)methyl]-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one

(1r,4r,5s)-4-(2-chloroethyl)-1-[(s)-(1s)-cyclohex-2-en-1-yl(hydroxy)methyl]-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one

C15H20ClNO4 (313.1081)


   

(2r)-2-amino-3-{[(2e)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-en-1-yl]sulfanyl}propanoic acid

(2r)-2-amino-3-{[(2e)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-en-1-yl]sulfanyl}propanoic acid

C14H19NO5S (313.0984)


   

(2s)-7-amino-2,4-dimethyl-2-(2-oxopropyl)naphtho[2,1-b]furan-1,6,9-trione

(2s)-7-amino-2,4-dimethyl-2-(2-oxopropyl)naphtho[2,1-b]furan-1,6,9-trione

C17H15NO5 (313.095)


   

2-{[(2e)-1-hydroxy-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-ylidene]amino}benzoic acid

2-{[(2e)-1-hydroxy-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-ylidene]amino}benzoic acid

C17H15NO5 (313.095)


   

(2s)-2-{[(2e)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-en-1-yl]amino}-3-sulfanylpropanoic acid

(2s)-2-{[(2e)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-en-1-yl]amino}-3-sulfanylpropanoic acid

C14H19NO5S (313.0984)


   

8,8-dichloro-n-(2-phenylethyl)oct-7-enimidic acid

8,8-dichloro-n-(2-phenylethyl)oct-7-enimidic acid

C16H21Cl2NO (313.1)


   

5-[(1r)-5-hydroxy-7-methoxy-3-oxo-1h-2-benzofuran-1-yl]-2-[(1e)-prop-1-en-1-yl]-1h-pyridin-4-one

5-[(1r)-5-hydroxy-7-methoxy-3-oxo-1h-2-benzofuran-1-yl]-2-[(1e)-prop-1-en-1-yl]-1h-pyridin-4-one

C17H15NO5 (313.095)


   

4-(2-chloroethyl)-1-[cyclohex-2-en-1-yl(hydroxy)methyl]-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one

4-(2-chloroethyl)-1-[cyclohex-2-en-1-yl(hydroxy)methyl]-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one

C15H20ClNO4 (313.1081)


   

7-amino-2,4-dimethyl-2-(2-oxopropyl)naphtho[2,1-b]furan-1,6,9-trione

7-amino-2,4-dimethyl-2-(2-oxopropyl)naphtho[2,1-b]furan-1,6,9-trione

C17H15NO5 (313.095)


   

(1r,4s,5s)-4-(2-chloroethyl)-1-[(s)-(1s)-cyclohex-2-en-1-yl(hydroxy)methyl]-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one

(1r,4s,5s)-4-(2-chloroethyl)-1-[(s)-(1s)-cyclohex-2-en-1-yl(hydroxy)methyl]-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one

C15H20ClNO4 (313.1081)


   

4,11-dimethoxy-5-methyl-2h-[1,3]dioxolo[4,5-b]acridin-10-one

4,11-dimethoxy-5-methyl-2h-[1,3]dioxolo[4,5-b]acridin-10-one

C17H15NO5 (313.095)


   

6,11-dimethoxy-5-methyl-2h-[1,3]dioxolo[4,5-b]acridin-10-one

6,11-dimethoxy-5-methyl-2h-[1,3]dioxolo[4,5-b]acridin-10-one

C17H15NO5 (313.095)


   

5-(5-hydroxy-7-methoxy-3-oxo-1h-2-benzofuran-1-yl)-2-(prop-1-en-1-yl)-1h-pyridin-4-one

5-(5-hydroxy-7-methoxy-3-oxo-1h-2-benzofuran-1-yl)-2-(prop-1-en-1-yl)-1h-pyridin-4-one

C17H15NO5 (313.095)